INOVIO PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Financing Activities in USD from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Inovio Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • Inovio Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $1.03M.
  • Inovio Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $51.5M, a 931% increase from 2023.
  • Inovio Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $5M, a 93.9% decline from 2022.
  • Inovio Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $81.8M, a 61.3% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

INOVIO PHARMACEUTICALS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $1.03M +$12.4M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q1 2024 -$11.4M -$10.9M -2576% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q1 2023 -$425K -$28.8M -101% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $28.4M -$132M -82.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $161M -$52.6M -24.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $214M +$135M +171% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $78.9M +$79.4M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 -$506K -$1.33M -161% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $826K +$757K +1089% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q1 2016 $69.5K +$69.5K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q1 2015 $0 -$69.9M -100% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q1 2014 $69.9M +$50.3M +257% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q1 2013 $19.6M +$19.6M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q1 2012 $0 -$24.3M -100% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q1 2011 $24.3M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09

INOVIO PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $51.5M +$46.5M +931% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-18
2023 $5M -$76.8M -93.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-18
2022 $81.8M -$130M -61.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $211M -$254M -54.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 $465M +$360M +341% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $105M +$74.4M +240% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $31M -$64.7M -67.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $95.7M +$87.9M +1129% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $7.79M -$76.6M -90.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 $84.4M +$11.9M +16.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 $72.5M +$19.8M +37.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 $52.7M +$47.4M +889% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 $5.33M -$22.7M -81% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 $28M +$37.7M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 -$9.69M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.